HQH / Abrdn Healthcare Investors - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Abrdn Healthcare Investors
US ˙ NYSE ˙ US87911J1034

Insider Shares202,938 shares
Total Insiders16
Insider Sentiment Score

The Insider Sentiment Score finds the companies being bought by corporate insiders.

It is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of insider accumulation. The scoring model uses a combination of the net number of insiders buying the prior 90 days, the total shares bought as a percentage of float, and the total shares owned by insiders. The number ranges from 0 to 100, with higher numbers indicating a higher level of accumulation to its peers, and 50 being the average.

Update Frequency: Daily

See Insiders Top Picks, which provides a list of companies with highest insider accumulation.

Officer Sentiment Score

The Officer Sentiment Score finds companies being bought by Corporate Officers.

By definition Corporate Officers are Corporate Insiders, but unlike some of the other Insiders (10% Shareholders and Board Members), Officers work for the company on a daily basis, and they user their own money when trading. (10% Shareholders and Board Members are often fund managers managing other people’s money.) As such, insider trades made by Officers are much more significant and should be treated appropriately.

Like the Insider Sentiment Score, the Officer Sentiment Score is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of officer accumulation.

Update Frequency: Daily

See Insiders Top Picks, which provides a list of companies with highest insider sentiment.

Key Insider Metrics

This card shows how the company ranks along various insider metrics. The percentile rank shows how this company compares to other companies in the US markets. Higher rankings are indicative of better situations.

For example, it is generally accepted that insider buying is a positive indicator, so companies with more insider buying would rank higher than companies with less insider buying (or even insider selling).

Net Number of Insiders Buying (Rank)

0 ( )

6373 out of 11305

Net Number of Insiders Buying is the total number of insiders buying minus the total number of insiders selling in the last 90 days. The percentile rank is shown here (range from 0 to 100%).

Percent of Float Bought by Insiders (Rank)

0.000 %( )

6302 out of 11224

Percent of Float Bought by Insiders is the total number of shares purchased by insiders minus the total number of shares sold by insiders in the last 90 days, divided by the total float and multiplied by 100.

Insider Trading Chart

Abrdn Healthcare Investors insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

Insider Roster and Profitability Metrics

This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings. Additionally, when possible we provide the historical trade performance for the insider. The historical trade performance is a weighted average of the performance of actual open-market purchase transactions made by the insider. For more information on how this is calculated, watch this YouTube webinar.

See our leaderboard of most profitable insider traders.

Insider Avg Profit (%) Shares
Owned
Split
Adjusted
Michael W Bonney Director - [D] 1,860 1,860
Jeffrey Allen Bailey Director - [D] 490 490
Rose DiMartino Director - [D] 1,000 1,000
Timothy L Gasperoni - 862 862
Kathleen Goetz Director - [D] 1,080 1,080
Insider Avg Profit (%) Shares
Owned
Split
Adjusted
Alan R Goodson Vice President - [O] 170 170
Thomas M Kent Director - [D] 1,100 1,100
Bill Maher Director - [D] 1,000 1,000
Elizabeth G Nabel Director - [D] 4,834 4,834
Rebecca Suzanne Nichols - 0 0
Insider Avg Profit (%) Shares
Owned
Split
Adjusted
Daniel R Omstead President, Director - [D] [O] 178,269 178,269
Oleg M Pohotsky Director - [D] 309 309
William S Reardon Director - [D] 1,470 1,470
Uwe E Reinhardt Director - [D] 2,982 2,982
Todd Reit Director - [D] 1,000 1,000
Lucinda H Stebbins Director - [D] 6,513 6,513

Report errors via our new Insider Auditing Tool

Track Records of Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in HQH / Abrdn Healthcare Investors. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2024-07-16 DiMartino Rose 1,000 18.8800 1,000 18.8800 18,880 36 19.6700 790 4.18
2024-04-09 Goetz Kathleen 525 16.4236 525 16.4236 8,622
2024-01-02 Reit Todd 1,000 16.9290 1,000 16.9290 16,929
2023-12-28 Maher Bill 1,000 16.5800 1,000 16.5800 16,580
2023-12-21 Goodson Alan R 170 16.1300 170 16.1300 2,742
2023-09-25 OMSTEAD DANIEL R 9,500 15.6332 9,500 15.6332 148,515
2023-09-20 OMSTEAD DANIEL R 9,500 15.8767 9,500 15.8767 150,829
2022-03-23 Goetz Kathleen 74 20.4158 74 20.4158 1,501
2022-01-26 Goetz Kathleen 481 21.5150 481 21.5150 10,349

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HQH / Abrdn Healthcare Investors Insider Trades
Track Records of Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in HQH / Abrdn Healthcare Investors. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HQH / Abrdn Healthcare Investors Insider Trades
Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2024-07-18 2024-07-16 4 DiMartino Rose HQH Common Stock P - Purchase D 18.8800 1,000 19 1,000
2024-06-18 3 Nichols Rebecca Suzanne HQH Common Shares D 0
2024-04-12 2024-04-09 4 Goetz Kathleen HQH Common Stock P - Purchase D 16.4236 525 9 1,080
2024-01-09 2023-12-21 4 Goodson Alan R HQH Common stock P - Purchase D 16.1300 170 3 170
2024-01-04 2024-01-02 4 Reit Todd HQH Common Stock P - Purchase D 16.9290 1,000 17 1,000
2024-01-02 2023-12-28 4 Maher Bill HQH Common Stock P - Purchase D 16.5800 1,000 17 1,000
2023-09-25 2023-09-25 4 OMSTEAD DANIEL R HQH Shares of Beneficial Interest P - Purchase D 15.6332 9,500 149 178,269
2023-09-20 2023-09-20 4 OMSTEAD DANIEL R HQH Shares of Beneficial Interest P - Purchase D 15.8767 9,500 151 168,769
2022-03-24 2022-03-23 4 Goetz Kathleen HQH Shares of Beneficial Interest P - Purchase D 20.4158 74 2 555
2022-01-27 2022-01-26 4 Goetz Kathleen HQH Shares of Beneficial Interest P - Purchase D 21.5150 481 10 481
2020-10-26 2020-10-26 4 OMSTEAD DANIEL R HQH Shares of Beneficial Interest P - Purchase D 20.5277 5,200 107 125,411
2020-10-21 2020-10-21 4 OMSTEAD DANIEL R HQH Shares of Beneficial Interest P - Purchase D 20.6787 5,050 104 120,211
2020-09-23 2020-09-23 4 Bailey Jeffrey Allen HQH Shares of Beneficial Interest P - Purchase D 20.3900 490 10 490
2020-05-22 2020-05-21 4 OMSTEAD DANIEL R HQH Shares of Beneficial Interest P - Purchase D 21.0108 5,000 105 110,357
2020-03-17 2020-03-17 4 OMSTEAD DANIEL R HQH Shares of Beneficial Interest P - Purchase D 16.2370 6,800 110 102,319
2018-12-26 2018-12-26 4 OMSTEAD DANIEL R HQH Shares of Beneficial Interest P - Purchase D 17.1382 6,300 108 85,406
2018-12-19 3 NABEL ELIZABETH G HQH Shares of Beneficial Interest D 4,834
2018-12-19 3 NABEL ELIZABETH G HQH Shares of Beneficial Interest D 4,834
2018-12-19 3 NABEL ELIZABETH G HQH Shares of Beneficial Interest D 4,834
2018-10-25 2018-10-25 4 OMSTEAD DANIEL R HQH Shares of Beneficial Interest P - Purchase D 20.4262 5,500 112 79,106
2018-10-17 2018-10-17 4 OMSTEAD DANIEL R HQH Shares of Beneficial Interest P - Purchase D 21.7760 3,882 85 73,606
2018-01-29 2018-01-25 4 Kent Thomas M HQH Shares of Beneficial Interest P - Purchase D 24.1862 1,100 27 1,100
2016-01-07 2016-01-06 4 Gasperoni Timothy L HQH Shares of Beneficial Interest P - Purchase D 28.9770 862 25 862
2015-06-29 2015-06-29 4 STEBBINS LUCINDA H HQH Shares of Beneficial Interest P - Purchase D 35.7400 -2,000 -71 6,513
2014-07-11 2014-06-24 4 REINHARDT UWE E HQH Subscription Rights X - Other D 25.04 -2,235 0
2014-07-11 2014-06-24 4 REINHARDT UWE E HQH Shares of Beneficial Interest X - Other D 25.0370 745 19 2,982
2014-07-01 2014-06-24 4 OMSTEAD DANIEL R HQH Subscription Rights X - Other D 25.04 -35,832 0
2014-07-01 2014-06-24 4 OMSTEAD DANIEL R HQH Shares of Beneficial Interest X - Other D 25.0370 11,944 299 47,780
2014-06-30 2014-06-24 4 BONNEY MICHAEL W HQH Subscription Rights X - Other D 25.04 -1,606 0
2014-06-30 2014-06-24 4 BONNEY MICHAEL W HQH Shares of Beneficial Interest X - Other D 25.0370 1,102 28 1,860
2014-06-30 2014-06-24 4 POHOTSKY OLEG M HQH Subscription Rights X - Other D 25.04 -231 0
2014-06-30 2014-06-24 4 POHOTSKY OLEG M HQH Shares of Beneficial Interest X - Other D 25.0370 77 2 309
2014-06-30 2014-06-24 4 REARDON WILLIAM S HQH Subscription Rights X - Other D 25.04 -1,226 0
2014-06-30 2014-06-24 4 REARDON WILLIAM S HQH Shares of Beneficial Interest X - Other D 25.0370 742 19 1,470
2014-06-30 2014-06-24 4 STEBBINS LUCINDA H HQH Subscription Rights X - Other D 25.04 -4,200 0
2014-06-30 2014-06-24 4 STEBBINS LUCINDA H HQH Shares of Beneficial Interest X - Other D 25.0370 1,400 35 8,513
2013-06-04 2013-06-04 4 OMSTEAD DANIEL R HQH Shares of Beneficial Interest P - Purchase D 21.4525 5,000 107 33,326
2012-03-21 2012-03-19 4 POHOTSKY OLEG M HQH Shares of beneficial interest P - Purchase D 15.9999 200 3 200
2012-03-12 2012-03-09 4 BONNEY MICHAEL W HQH Shares of Beneficial Interest P - Purchase D 15.7966 650 10 650
2012-03-12 2012-03-09 4 REARDON WILLIAM S HQH Shares of Beneficial Interest P - Purchase D 15.8551 646 10 646
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista